Release of a Poorly Soluble Drug from Hydrophobically Modified Poly (Acrylic Acid) in Simulated Intestinal Fluids.

A large part of new pharmaceutical substances are characterized by a poor solubility and high hydrophobicity, which might lead to a difference in drug adsorption between fasted and fed patients. We have previously evaluated the release of hydrophobic drugs from tablets based on Pemulen TR2 and showe...

Full description

Bibliographic Details
Main Authors: Patrik Knöös, Anna V Svensson, Stefan Ulvenlund, Marie Wahlgren
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4608824?pdf=render
id doaj-9112970624f245668744d3990950fa14
record_format Article
spelling doaj-9112970624f245668744d3990950fa142020-11-25T01:49:04ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011010e014070910.1371/journal.pone.0140709Release of a Poorly Soluble Drug from Hydrophobically Modified Poly (Acrylic Acid) in Simulated Intestinal Fluids.Patrik KnöösAnna V SvenssonStefan UlvenlundMarie WahlgrenA large part of new pharmaceutical substances are characterized by a poor solubility and high hydrophobicity, which might lead to a difference in drug adsorption between fasted and fed patients. We have previously evaluated the release of hydrophobic drugs from tablets based on Pemulen TR2 and showed that the release can be manipulated by adding surfactants. Here we further evaluate the possibility to use Pemulen TR2 in controlled release tablet formulations containing a poorly soluble substance, griseofulvin. The release is evaluated in simulated intestinal media that model the fasted state (FaSSIF medium) or fed state (FeSSIF). The rheology of polymer gels is studied in separate experiments, in order to gain more information on possible interactions. The release of griseofulvin in tablets without surfactant varied greatly and the slowest release were observed in FeSSIF. Addition of SDS to the tablets eliminated the differences and all tablets showed a slow linear release, which is of obvious relevance for robust drug delivery. Comparing the data from the release studies and the rheology experiment showed that the effects on the release from the different media could to a large extent be rationalised as a consequence of the interactions between the polymer and the surfactants in the media. The study shows that Pemulen TR2 is a candidate for controlled release formulations in which addition of surfactant provides a way to eliminate food effects on the release profile. However, the formulation used needs to be designed to give a faster release rate than the tablets currently investigated.http://europepmc.org/articles/PMC4608824?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Patrik Knöös
Anna V Svensson
Stefan Ulvenlund
Marie Wahlgren
spellingShingle Patrik Knöös
Anna V Svensson
Stefan Ulvenlund
Marie Wahlgren
Release of a Poorly Soluble Drug from Hydrophobically Modified Poly (Acrylic Acid) in Simulated Intestinal Fluids.
PLoS ONE
author_facet Patrik Knöös
Anna V Svensson
Stefan Ulvenlund
Marie Wahlgren
author_sort Patrik Knöös
title Release of a Poorly Soluble Drug from Hydrophobically Modified Poly (Acrylic Acid) in Simulated Intestinal Fluids.
title_short Release of a Poorly Soluble Drug from Hydrophobically Modified Poly (Acrylic Acid) in Simulated Intestinal Fluids.
title_full Release of a Poorly Soluble Drug from Hydrophobically Modified Poly (Acrylic Acid) in Simulated Intestinal Fluids.
title_fullStr Release of a Poorly Soluble Drug from Hydrophobically Modified Poly (Acrylic Acid) in Simulated Intestinal Fluids.
title_full_unstemmed Release of a Poorly Soluble Drug from Hydrophobically Modified Poly (Acrylic Acid) in Simulated Intestinal Fluids.
title_sort release of a poorly soluble drug from hydrophobically modified poly (acrylic acid) in simulated intestinal fluids.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description A large part of new pharmaceutical substances are characterized by a poor solubility and high hydrophobicity, which might lead to a difference in drug adsorption between fasted and fed patients. We have previously evaluated the release of hydrophobic drugs from tablets based on Pemulen TR2 and showed that the release can be manipulated by adding surfactants. Here we further evaluate the possibility to use Pemulen TR2 in controlled release tablet formulations containing a poorly soluble substance, griseofulvin. The release is evaluated in simulated intestinal media that model the fasted state (FaSSIF medium) or fed state (FeSSIF). The rheology of polymer gels is studied in separate experiments, in order to gain more information on possible interactions. The release of griseofulvin in tablets without surfactant varied greatly and the slowest release were observed in FeSSIF. Addition of SDS to the tablets eliminated the differences and all tablets showed a slow linear release, which is of obvious relevance for robust drug delivery. Comparing the data from the release studies and the rheology experiment showed that the effects on the release from the different media could to a large extent be rationalised as a consequence of the interactions between the polymer and the surfactants in the media. The study shows that Pemulen TR2 is a candidate for controlled release formulations in which addition of surfactant provides a way to eliminate food effects on the release profile. However, the formulation used needs to be designed to give a faster release rate than the tablets currently investigated.
url http://europepmc.org/articles/PMC4608824?pdf=render
work_keys_str_mv AT patrikknoos releaseofapoorlysolubledrugfromhydrophobicallymodifiedpolyacrylicacidinsimulatedintestinalfluids
AT annavsvensson releaseofapoorlysolubledrugfromhydrophobicallymodifiedpolyacrylicacidinsimulatedintestinalfluids
AT stefanulvenlund releaseofapoorlysolubledrugfromhydrophobicallymodifiedpolyacrylicacidinsimulatedintestinalfluids
AT mariewahlgren releaseofapoorlysolubledrugfromhydrophobicallymodifiedpolyacrylicacidinsimulatedintestinalfluids
_version_ 1725009148285812736